Fortis Healthcare Earnings/Conference Calls

Fortis Healthcare earnings concalls and investor presentations

Load latest

Fortis Healthcare Ltd.

11 Nov 2023

904.85

-1.55%

Earnings Call

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the investors / analysts meet held on November 10, 2023 to discuss the Company's un-audited financial results for the quarter and period ended September 30, 2023 is available on the website of the Company.

pdf

Fortis Healthcare Ltd.

10 Nov 2023

904.85

-1.55%

Investor Presentation

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Reg 30 of SEBI LODR, please find enclosed press release and earnings presentation for the quarter and period ended September 30, 2023.

pdf

Fortis Healthcare Ltd.

11 Aug 2023

904.85

-1.55%

Earnings Call

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Reg. 30 of SEBI LODR, please find enclosed herewith the Transcript of the investors / analysts meet held on August 7, 2023 to discuss the Company''s un-audited financial results for the quarter ended June 30, 2023.

pdf

Fortis Healthcare Ltd.

07 Aug 2023

904.85

-1.55%

Earnings Call

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the investors / analysts meet held on August 7, 2023 to discuss the Company's un-audited financial results for the quarter ended June 30, 2023 is available on the website of the Company.

pdf

Fortis Healthcare Ltd.

04 Aug 2023

904.85

-1.55%

Investor Presentation

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Reg. 30 of SEBI LODR, please find enclosed herewith the Press Release and Earnings Presentation for the Quarter ended June 30, 2023

pdf

Fortis Healthcare Ltd.

26 May 2023

904.85

-1.55%

Earnings Call

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Transcript of the investors / analysts meet held on May 24, 2023 to discuss the Company's audited financial results for the quarter and financial year ended March 31, 2023. Further, the said transcript is also available on the website of the Company.

pdf

Fortis Healthcare Ltd.

25 May 2023

904.85

-1.55%

Earnings Call

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the investors / analysts meet held on May 24, 2023 to discuss the Company's audited financial results for the quarter and financial year ended March 31, 2023 is available on the website of the Company.

pdf

Fortis Healthcare Ltd.

23 May 2023

904.85

-1.55%

Investor Presentation

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed herewith the press release and earnings presentation for the quarter and financial year ended on March 31, 2023. This is for your information and record

pdf

Fortis Healthcare Ltd.

16 Feb 2023

904.85

-1.55%

Earnings Call

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Transcript of the investors / analysts meet held on February 13, 2023 to discuss the Company's un-audited financial results for the quarter ended December 31, 2022. Further, the said transcript is also available on the website of the Company i.e. https://www.fortishealthcare.com/investors.

pdf

Fortis Healthcare Ltd.

14 Feb 2023

904.85

-1.55%

Earnings Call

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the investors / analysts meet held on February 13, 2023 to discuss the Company's un-audited financial results for the quarter ended December 31, 2022 is available on the website of the Company i.e. https://www.fortishealthcare.com/investors.

pdf

Is Fortis Healthcare Ltd. worth buying?

335 Votes:

Buy 77.91%

Sell 10.75%

Hold 11.34%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf